Stockholders’ Equity (Details) - USD ($) |
1 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 14, 2021 |
Aug. 10, 2021 |
Jul. 14, 2021 |
Jan. 06, 2021 |
Sep. 17, 2021 |
Jun. 01, 2021 |
Feb. 28, 2021 |
May 31, 2020 |
Sep. 30, 2021 |
Sep. 30, 2020 |
Sep. 30, 2021 |
Sep. 30, 2020 |
Dec. 31, 2020 |
Jul. 31, 2021 |
|
| Stockholders’ Equity (Textual) | ||||||||||||||
| Common stock per share (in Dollars per share) | $ 0.001 | $ 0.001 | $ 0.001 | |||||||||||
| Convertible Preferred Stock Shares Issued (in Shares) | 65,953 | |||||||||||||
| (in Shares) | 25,062 | |||||||||||||
| Warrants to purchase common stock, description | On January 6, 2021, The Company issued 72,369 shares of common stock and 90,461 5 year warrants to purchase shares of common stock at $4.00 per share pursuant to the prior receipt of $275,000 in equity financing. | |||||||||||||
| Common shares issued (in Shares) | 298,883 | 11,060,656 | 11,060,656 | 9,895,600 | ||||||||||
| Common stock placement (in Shares) | 298,883 | |||||||||||||
| Warrant additional | 5 years | |||||||||||||
| Warrant to purchase price | $ 1.79 | |||||||||||||
| Aggregate gross proceeds | $ 525,000 | |||||||||||||
| Common stock shares issued | $ 27,403 | $ 5,458 | $ 29,025 | $ 96,757 | $ 191,078 | $ 847,200 | $ 323,635 | $ 2,605,390 | ||||||
| Accounts payable | $ 132,557 | |||||||||||||
| Fair value price per share (in Dollars per share) | $ 2.26 | $ 2.55 | $ 2.95 | $ 1.37 | ||||||||||
| Accounts payable | $ 61,930 | $ 13,919 | $ 85,622 | |||||||||||
| Common stock shares issued | 11,611 | |||||||||||||
| Accounts payable | $ 29,607 | |||||||||||||
| Fair value price per share (in Dollars per share) | $ 2.55 | |||||||||||||
| Stockholders’ equity description | the Company received $515,000 of a committed $565,000 from the sale of 135,527 shares of common stock (at a price of $3.80 per share) and warrants to purchase 169,409 shares of common stock, at an exercise price of $4.00 per share. As of September 30, 2021, the full amount has not been received and only $415,000 worth of the shares and warrants have been issued. The remaining $125,000 is included in equity financing within current liabilities on the consolidated balance sheet. | |||||||||||||
| Unrecognized expense | $ 1,700,000 | $ 2,500,000 | ||||||||||||
| Vested Restricted Stock Units [Member] | ||||||||||||||
| Stockholders’ Equity (Textual) | ||||||||||||||
| Stock conversion, description | Between January 25, 2021 and August 13, 2021, the company issued a total of 504,965 shares of common stock to holders of fully vested restricted stock units. | |||||||||||||
| Maximum [Member] | ||||||||||||||
| Stockholders’ Equity (Textual) | ||||||||||||||
| Unrecognized expenses to be recognized, term | 4 years | |||||||||||||
| Minimum [Member] | ||||||||||||||
| Stockholders’ Equity (Textual) | ||||||||||||||
| Unrecognized expenses to be recognized, term | 3 years | |||||||||||||
| Common Stock [Member] | ||||||||||||||
| Stockholders’ Equity (Textual) | ||||||||||||||
| Common stock, shares authorized (in Shares) | 45,000,000 | 45,000,000 | ||||||||||||
| Common stock shares issued | $ 73 | $ 157 | $ 170 | $ 442 | ||||||||||
| Series A Convertible Preferred Stock [Member] | ||||||||||||||
| Stockholders’ Equity (Textual) | ||||||||||||||
| Preferred stock, shares authorized (in Shares) | 900,000 | 900,000 | ||||||||||||
| Stock conversion, description | During February 2021, the Company issued 52,632 shares of common stock to a holder of its Series A Convertible Preferred Stock upon the conversion of 20,000 of such shares of Series A Convertible Preferred Stock. | |||||||||||||